Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000279364 (AC114546.3) is annotated as a long non-coding RNA (lncRNA). It has been reported in gene expression studies as downregulated in certain disease comparisons (e.g., heart failure vs. myocardial fibrosis), but there is no evidence or recognized functional characterization as a therapeutic target, protein, or disease biomarker in the current biomedical literature. No protein product, molecular interactions, or mechanistic roles have been described[3]. This entry is not suitable as a canonical drug target or receptor due to lack of supporting evidence for protein-coding function, therapeutic targeting, or major molecular or disease associations[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AC114546.3.